958293-79-3 Usage
Uses
Used in Pharmaceutical Industry:
Naproxen-d3 is used as a nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain, inflammation, and fever. It works by inhibiting the production of prostaglandins, which are responsible for inflammation and pain in the body.
Used in Research and Development:
Naproxen-d3 can be used as a labeled compound in research and development for studying the metabolism, distribution, and excretion of Naproxen in biological systems. The deuterium-labeled version allows for easier detection and tracking of the compound in various assays and experiments.
Used in Drug Metabolism Studies:
Naproxen-d3 can be used in drug metabolism studies to investigate the metabolic pathways and enzymes involved in the breakdown of Naproxen. This information can be valuable for understanding the pharmacokinetics and pharmacodynamics of the drug, as well as for the development of new drugs with improved properties.
Used in Sports Medicine:
Naproxen-d3 can be used in sports medicine as an anti-inflammatory and analgesic agent to help athletes manage pain and inflammation caused by injuries or overexertion during training and competitions.
Used in Veterinary Medicine:
Naproxen-d3 can also be used in veterinary medicine for the treatment of pain, inflammation, and fever in animals. It can be particularly useful in cases where traditional NSAIDs may not be suitable or effective.
Check Digit Verification of cas no
The CAS Registry Mumber 958293-79-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,2,9 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 958293-79:
(8*9)+(7*5)+(6*8)+(5*2)+(4*9)+(3*3)+(2*7)+(1*9)=233
233 % 10 = 3
So 958293-79-3 is a valid CAS Registry Number.
958293-79-3Relevant academic research and scientific papers
NAPTHYLENE INHIBITORS OF CYCLOOXYGENASE
-
Page/Page column 33, (2010/11/18)
The present invention relates to new napthylene inhibitors of cyclooxygenase activity, pharmaceutical compositions thereof, and methods of use thereof.
